Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2000 1
2002 1
2003 3
2005 1
2006 1
2007 3
2008 3
2010 2
2011 3
2012 5
2014 4
2015 4
2016 4
2017 4
2018 5
2019 5
2020 6
2021 2
2022 1
2023 4
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
[The ATTR-ACT trial].
Rapezzi C, Gagliardi C, Milandri A. Rapezzi C, et al. Among authors: milandri a. G Ital Cardiol (Rome). 2019 Jun;20(6):335-337. doi: 10.1714/3165.31465. G Ital Cardiol (Rome). 2019. PMID: 31184318 Italian. No abstract available.
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
Kaski JP, Norrish G, Gimeno Blanes JR, Charron P, Elliott P, Tavazzi L, Tendera M, Laroche C, Maggioni AP, Baban A, Khraiche D, Ziolkowska L, Limongelli G, Ojala T, Gorenflo M, Anastasakis A, Mostafa S, Caforio ALP; EORP Paediatric Cardiomyopathy Registry Investigators. Kaski JP, et al. Eur Heart J. 2024 Apr 21;45(16):1443-1454. doi: 10.1093/eurheartj/ehae109. Eur Heart J. 2024. PMID: 38427064 Free PMC article.
A targeted proteomics approach to amyloidosis typing.
Conti M, Poppi I, Cavedagna TM, Zamagni E, Leone O, Corti B, Milandri A, Bacci F, Ramazzotti E, Mancini R, Cavo M, Quarta CC, Rapezzi C. Conti M, et al. Among authors: milandri a. Clin Mass Spectrom. 2018 Feb 13;7:18-28. doi: 10.1016/j.clinms.2018.02.001. eCollection 2018 Jan. Clin Mass Spectrom. 2018. PMID: 39193554 Free PMC article.
Electrocardiographic abnormalities in patients with cardiomyopathies.
Aimo A, Milandri A, Barison A, Pezzato A, Morfino P, Vergaro G, Merlo M, Argirò A, Olivotto I, Emdin M, Finocchiaro G, Sinagra G, Elliott P, Rapezzi C. Aimo A, et al. Among authors: milandri a. Heart Fail Rev. 2024 Jan;29(1):151-164. doi: 10.1007/s10741-023-10358-7. Epub 2023 Oct 17. Heart Fail Rev. 2024. PMID: 37848591 Free PMC article. Review.
Cardiac amyloidosis: the great pretender.
Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I, Salvi F, Maurer MS. Rapezzi C, et al. Among authors: milandri a. Heart Fail Rev. 2015 Mar;20(2):117-24. doi: 10.1007/s10741-015-9480-0. Heart Fail Rev. 2015. PMID: 25758359 Review.
The Authors Reply.
Rapezzi C, Lorenzini M, Milandri A, Gagliardi C, Longhi S. Rapezzi C, et al. Among authors: milandri a. JACC Cardiovasc Imaging. 2016 Jul;9(7):906. doi: 10.1016/j.jcmg.2015.11.019. Epub 2016 Apr 13. JACC Cardiovasc Imaging. 2016. PMID: 27085436 Free article. No abstract available.
57 results